SEC Tracker
Get the app

Possible new RKDA shares

RKDADilution

Known so far: no new shares from the prospectus covers read · shelf room about $1.9M · not yet read: warrants, converts, options, ATM.

Shelf room

  • Room today about $1.9M
  • One third of float $1.9M ($5.7M float, Jun 30, 2025)
  • Sold off it, 12 months nothing
How this is worked out

Shelf room about $1.9M on the S-3 of Jun 26, 2026: the baby-shelf rule (public float under $75M) caps sales at one third of the $5.7M public float stated as of Jun 30, 2025, $1.9M, nothing sold off it in the last 12 months. Sources: S-3 Jun 26, 2026, effective Jul 8, 2026 · public float, as of Jun 30, 2025.

What could become new Arcadia Biosciences (RKDA) shares, from its 10-Q, 10-K, S-3 or 424B filings.

Read so far: the cover share count (2.4M shares, +76% from 1.4M on Aug 7, 2025). Not read yet: warrants, convertible notes, options and RSUs and an ATM program. Read them on EDGAR: the latest 10-Q · S-3 shelf filings.

Shares outstanding

2.4M

Nov 2024 to Aug 2026: from 1.4M to 2.4M.

From the share count on the cover of each 10-Q and 10-K, dated as each cover states.